Roggwil, April 2, 2023 – On March 31, 2023, an exclusive distribution partnership was signed with one of the largest medical technology distributors in China. This market, with 1.4 billion inhabitants, is arguably the most interesting sales market in the world, as due to the lifted COVID restrictions, there have been 37 million new infections reported daily. About 15% of all COVID survivors subsequently have tinnitus, and therefore, 210 million new tinnitus patients are expected there.

++ About Resaphene Suisse AG

Resaphene Suisse AG, based in Roggwil, Switzerland, is a medical technology company that was founded in 2015 and has been selling a tinnitus therapy device under the name tinniwell since 2016.

++ Contact for inquiries:

Resaphene Suisse AG
Ms. Anke Rauterkus (Chief Executive Officer)
Bahnhofplatz 5
9322 Egnach
Switzerland

T. +41 714500668
a.rauterkus@resaphene.ch